DATAMEDS AI INC
MEDSNASDAQTrading Snapshot
- Day Range
- $3.63 – $3.73
- 52-Week Range
- $0.82 – $73.00
- Volume
- $2.54B
- Avg Volume
- $1.84B
- Shares Outstanding
- 2.6M
- Next Earnings
- Dec 11, 2026
Fundamentals Snapshot
- Annual Revenue
- $23M
- Last Q Revenue
- $2M
- P/E Ratio
- -0.1
- P/S Ratio
- 1.2x
- EPS (TTM)
- $-34.29
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +36.7%
Why Investors Own MEDS
- ✓High-growth profile — revenue up +48.3% YoY with expanding US Equity exposure.
- ✓Healthy economics — 25% gross margin and 9% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
DATAMEDS AI INC
MEDS
StockOtter · stockotter.spaceAbout DATAMEDS AI INC
DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
Wellgistics Health, Inc. (NASDAQ:MEDS) Stock Short Interest Rises 147.5%
Wellgistics Health, Inc. (NASDAQ: MEDS - Get Free Report) was the recipient of a significant increase in short interest during the month of September. As of September 15th, there was short interest totaling 430,628 share
DataMeds AI Stock Surges on Mobile App Launch
DataMeds AI Inc. (NASDAQ:MEDS) shares are surging Monday morning following the launch of its "Health Lives Here" mobile application, a joint initiative with Tollo Health and the NFL Alumni Association.
DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application
Healthcare IT Company and Nutritional Products Maker to Work with NFL Alumni Health to Drive Awareness of GLP-1 Telehealth and Pharmacy Services TAMPA, FL / ACCESS Newswire / September 28, 2026 / DataMeds AI, Inc. (NASDA
DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit
Interim Co-CEO to Discuss Growing Patient Desire to Own Health Data TAMPA, FL / ACCESS Newswire / September 25, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company l
DataMEDS AI Unveils New Corporate Website
Updated Website Aligns with Pending Marketing Initiatives Following Recent Acquisition of Helomics CLIA-certified Laboratory and Litigation Settlement TAMPA, FL / ACCESS Newswire / September 21, 2026 / DataMEDS AI, Inc.
DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked
TAMPA, FL / ACCESS Newswire / September 18, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with it